Aggressive Systemic Mastocytosis (ASM)

specific

An aggressive and progressive mast cell neoplasm characterized by systemic infiltration of internal organs by aggregates of neoplastic mast cells. There is no evidence of mast cell leukemia or clonal hematologic malignancy. Clinical symptoms include hepatomegaly, splenomegaly, portal hypertension, malabsorption syndrome, and pathologic fractures.

14

Centers

14

Active Trials

Cancer Funding

Top Centers for Aggressive Systemic Mastocytosis (ASM)(14)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.6
2
NCI Comprehensive
Active Research Program
53.6
3
NCI Comprehensive
Active Research Program
53.6
4
NCI Comprehensive
Active Research Program
53.6
5
NCI Comprehensive
Active Research Program
53.6
6
NCI Comprehensive
Active Research Program
53.6
7
NCI Comprehensive
Active Research Program
53.6
8
NCI Comprehensive
Active Research Program
53.6
9
Active Research Program
53.6
10
Active Research Program
53.6
11
Active Research Program
53.6
12
Active Research Program
53.6
13
Active Research Program
53.6
14
Active Research Program
53.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →